Your browser does not support JavaScript!
Google  

 

 

:::
[2015/01/13]Professor Shuu-Jiun Wang and His Team Win a 17th National Biotechnology & Medical Care Quality Award

[2015/01/13]

Professor Shuu-Jiun Wang and His Team Win a 17th National Biotechnology & Medical Care Quality Award

Professor Shuu-Jiun Wang, Chairman of the Faculty of Medicine of NYMU, and his team, were recently awarded the Copper Medal of the 17th National Biotechnology & Medical Care Quality Award. The competition included medical teams representing the top medical centers from all over the country.The NYMU-TVGH Headache Team was established in 1996 by Professor Shuu-Jiun Wang in collaboration with Professor Jong-Ling Fuh. This team not only developed a paradigm of care for headache patients characterized by high affordability, availability, and accessibility, but also set up standardized treatment protocols for the management of headache disorders for both outpatients and inpatients. In particular, the quality of care of three special headache disorders, namely medication-overuse headache, reversible cerebral vasoconstriction syndromes, and spontaneous intracranial hypotension, was determined to be comparable to or better than that of top headache centers from around the globe. More than 90% of the patients treated were satisfied with their care.

For medication-overuse headache, the NYMU-TVGH Headache Team has identified unique clinical patterns specific to Taiwanese patients, and developed in-hospital treatment programs for detoxification. In addition, this team has completed a series of studies based on the world's largest patient cohort with reversible cerebral vasoconstriction syndromes. Remarkable achievements included: 1) Demonstration of the treatment efficacy of the calcium channel blocker; and, 2) Stratification of the risk of ischemic stroke based on the findings of brain magnetic resonance angiography and transcranial color-coded sonography. Moreover, in collaboration with Professor Jiing-Feng Lirng at the Department of Radiology of TVGH, this team also developed a heavily T2-weighted magnetic resonance myelography, a non-invasive imaging technique to demonstrate and follow-up cerebrospinal fluid leakage in patients with low pressure headache due to spontaneous intracranial hypotension. With the advent of this revolutionary imaging technique, early treatment with epidural blood patching, done by Dr. Shu-Shya Hseu or her colleagues at the Department of Anesthesiology of TVGH, is made feasible, which leads to early recovery and reduced complications. Professor Shuu-Jiun Wang delivered a speech on this technique as a recipient of the Seymour Solomon Presidential Lecture Award at the 2010 annual meeting of American Headache Society at Los Angeles, CA, USA.

Professor Chen said in the past for osteosarcoma patients, amputation is the only option to survive. In recent years, with advances in chemotherapy, osteosarcoma tumor resection without the need for amputation of limb salvage reconstructive surgery (limb salvage procedure) has gradually become the mainstream treatment. But the research team found that with increasing length of survival of patients with this type of tumor, the artificial joint that the patients wearwould gradually loosen. The patient then must once again undergo the surgery and will possibly hurt the residual bone, and the final result in patients requiring prolonged wheelchair walker. Professor Chen's mentor, vice president of TPEVGH, Tain-Hsiung Chen, in January 1991 first introduced vitro irradiation (extracorporeal irradiation) autologous bone reconstructive surgery, which you cut the cancer bone first and then administration of high-dose radiation exposure in vitro to kill tumor cells. Lastly replanted back the bone into the body, the results are satisfied. The research team also began in 2005 with the use of liquid nitrogen cryogenic freezing to remove tumor cells, concurrent now appropriate antifreeze protection, and liquid nitrogen freezing method can more effectively protect the cartilage. At present, the use of these technologies has been quite skillful, accumulated experience more attractive to foreign physicians comes to learn.

According to Professor Shuu-Jiun Wang, the preparation of the competition for the Symbol of National Quality award provided an opportunity to optimize their standard of care, as many of the treatment protocols were scrutinized and optimized during the process. Besides, this award represents appreciation and recognition of their efforts in the past and fuels their enthusiasm to keep moving forward into the future of headache treatment and understanding. They will continue to provide state-of-the-art clinical services for headache patients from Taiwan and other parts of the world, with the goal to achieve an era free of medical disability due to headache.

Professor Wang and His Team Win a 17th National Biotechnology & Medical Care Quality Award

Professor Wang(left 3) and His Team Win a 17th National Biotechnology & Medical Care Quality Award


views